0001104659-22-011497.txt : 20220203 0001104659-22-011497.hdr.sgml : 20220203 20220203190610 ACCESSION NUMBER: 0001104659-22-011497 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220201 FILED AS OF DATE: 20220203 DATE AS OF CHANGE: 20220203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TYLE PRAVEEN CENTRAL INDEX KEY: 0001296936 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36672 FILM NUMBER: 22590283 MAIL ADDRESS: STREET 1: ONE BAUSCH & LOMB PLACE CITY: ROCHESTER STATE: NY ZIP: 14604 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KIORA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001372514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1371 EAST 2100 SOUTH STREET 2: SUITE 200 CITY: SALT LAKE CITY STATE: UT ZIP: 84105 BUSINESS PHONE: (781) 788-8869 MAIL ADDRESS: STREET 1: 1371 EAST 2100 SOUTH STREET 2: SUITE 200 CITY: SALT LAKE CITY STATE: UT ZIP: 84105 FORMER COMPANY: FORMER CONFORMED NAME: EYEGATE PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060811 4 1 tm225348d9_4.xml OWNERSHIP DOCUMENT X0306 4 2022-02-01 0 0001372514 KIORA PHARMACEUTICALS INC KPRX 0001296936 TYLE PRAVEEN C/O KIORA PHARMACEUTICALS, INC. 1371 E. 2100 SOUTH, SUITE 200 SALT LAKE CITY UT 84105 1 0 0 0 Stock Option (right to buy) 0.77 2022-02-01 4 A 0 5000 0 A 2032-02-01 Common Stock 5000 5000 D The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2023. /s/ Sarah Romano, Attorney-in-Fact* 2022-02-03